Wird geladen...
Immune checkpoint inhibitors in small cell lung cancer
Small cell lung cancer (SCLC) is a rapidly progressive cancer that often debilitates patients within months of detection and quickly becomes refractory to the limited options of therapy. While SCLC is not generally considered an immunogenic tumor, clinical experience suggests that patients with robu...
Gespeichert in:
| Veröffentlicht in: | J Thorac Dis |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
AME Publishing Company
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5861263/ https://ncbi.nlm.nih.gov/pubmed/29593891 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2017.12.51 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|